Newborn screening testing services for brian allgood community hospital (baach)/121ST combat support hospital (CSH), usameddac-korea. Base period (29 SEP 2019 - 28 SEP 2020) plus four (4) one-year…
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- W81K0219D0011
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 6 $204,927 obligated
Award facts
- Opportunity
-
- W81K0219Q0218 Solicitation number
- Newborn Screening Testing Services for U. S. Army Medical Department Activity, Korea Award Notice · Posted Aug 12, 2019
- Combined order value
- $204,927 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 55% used
- $375,013.10
- Maximum order
- $375,013.10
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The key products and services being delivered under this indefinite delivery contract (IDC) awarded by the Defense Health Agency (DHA) are newborn screening testing services for the Brian Allgood Community Hospital (BAACH) and 121st Combat Support Hospital (CSH) in South Korea.
The prime contractor, Revvity Omics Inc. (doing business as Perkinelmer Genetics), a subsidiary of Revvity Inc., will perform this work at its own facilities in Pittsburgh, Pennsylvania. The contract has a total ceiling value of $375,013.10 and a period of performance from September 29, 2019 through September 28, 2024, with a base period and four one-year option periods. The contract was awarded as a single-award IDC with no set-aside designations. The contracted services entail conducting newborn screening tests to detect conditions like galactosemia, hypothyroidism, sickle cell disease, and cystic fibrosis, allowing for early diagnosis and treatment to support the military healthcare system and families stationed in Korea.
Description
Newborn screening testing services for brian allgood community hospital (baach)/121ST combat support hospital (CSH), usameddac-korea. Base period (29 SEP 2019 - 28 SEP 2020) plus four (4) one-year option periods.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Vendor DUNS or Name Change - Non-Novation | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract W81K0219D0011?
W81K0219D0011 was awarded to Revvity Omics Inc. by Medical Command (Department of the Army) on September 29, 2019.
How much is contract W81K0219D0011 worth?
Orders under W81K0219D0011 have obligated $204,927. W81K0219D0011's own ceiling is $375,013. A single order can be worth up to $375,013.
How many orders have been placed under contract W81K0219D0011?
6 orders have been placed under W81K0219D0011, the latest on September 29, 2023.
Which agency awarded contract W81K0219D0011?
Medical Command (Department of the Army) awarded W81K0219D0011, with funding from Defense Health Agency (Department of Defense).
Who can order from contract W81K0219D0011?
W81K0219D0011 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract W81K0219D0011 competed?
The extent of competition for W81K0219D0011 was competed under sap. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV